ICD-10 Coding for Uterus Carcinoma(C53.9, C53.9C, C53.9I)
Comprehensive guide on ICD-10 coding for uterus carcinoma, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Uterus Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C54.1 | Malignant neoplasm of endometrium | Use when the primary site of the carcinoma is confirmed to be the endometrium. |
|
| C79.82 | Secondary malignant neoplasm of genital organs | Use when documenting secondary malignancies in genital organs. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutUterus Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Uterus Carcinoma.
Lack of specific histological documentation
Impact
Clinical: Inaccurate diagnosis leading to inappropriate treatment., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims due to insufficient documentation.
Mitigation
Ensure detailed histological reports are included in patient records.
Confusing C54.1 with C54.2 or C53.9
Impact
Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation
Verify the primary site of the tumor through histological reports.
Histological documentation
Impact
Lack of detailed histological documentation can lead to audit issues.
Mitigation
Ensure all histological findings are thoroughly documented.